亚洲精品久久无码2021,偷拍亚洲另类无码专区制服,亚洲欧美性都花花世界,国产熟女的精品视频大全,色偷偷2025免费视频观看,撅着大腚SXMV色香视频

A few days ago, the Department of Planning, Development and Information Technology of the National Health and Medical Commission issued the "Notice of the Office of the Healthy China Action Promotion Committee on Printing and Distributing the Work Points of the Healthy China Action in 2022".

 

The notice emphasizes that cervical cancer, cancer screening, cardiovascular and cerebrovascular, respiratory, and metabolic diseases, early screening of primary respiratory diseases, hypertension, diabetes and other chronic diseases, and normalized prevention and control of the COVID-19 pneumonia epidemic will be the key work directions in 2022. At the same time, the implementation of China's Action Plan to Eliminate Mother-to-Child Transmission of AIDS, Syphilis and Hepatitis B was launched.

 

With the continuous introduction of national policies in recent years, early cancer screening, cervical cancer screening and prevention, and respiratory diseases have become the key work directions of the National Health Commission, major enterprises in related industries have already deployed according to the policies.

 

Early tumor screening

There are nearly 200 companies engaged in "early tumor screening" related businesses across the country. Including New Horizon Health Ltd, Berry Genomics Co.,Ltd, Burning Rock Biotech. Creative Biosciences (Guangzhou) Co., Ltd……

 

Cervical Cancer Screening

Cervical cancer is also the main market that major IVD companies compete for. Previously, the National Health and Health Commission issued the "Cervical Cancer Screening Work Plan", which clearly stated that high-risk HPV detection methods can be used as one of the primary screening programs. The technology platform and its products must contain at least 14 high-risk types clearly identified by the World Health Organization, including: HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, etc.

 

respiratory disease

The respiratory field is a market that IVD companies have begun to attach importance to after the COVID-19 epidemic. On March 1, 2021, the National Health and Medical Commission and the Hospital Administration issued the "2021 National Medical Quality and Safety Improvement Targets", aiming at the current medical quality and safety. There are weak links and key areas, and 33 improvement goals are proposed.

The article sorts out the key work directions of the National Health Commission related to the direction of IVD as follows:

 

Priority 1: Formulate the Action Plan to Accelerate the Elimination of Cervical Cancer to promote comprehensive prevention and treatment of cervical cancer. Launched the implementation of China's Action Plan to Eliminate Mother-to-Child Transmission of AIDS, Syphilis and Hepatitis B. （The National Health Commission）

Priority 2: Further expand the coverage of the "three-high" co-management pilot program and advance the legislative process of pre-hospital medical emergency related regulations. (The National Health Commission)

 

Priority 3: Focus on the needs for the prevention and treatment of major diseases such as cancer, cardiovascular and cerebrovascular, respiratory, and metabolic diseases, and accelerate the launch and implementation of the major project of science and technology innovation “Research on the Prevention and Treatment of Cancer, Cardio-cerebrovascular, Respiratory and Metabolic Diseases (2030)”. (The Ministry of Science and Technology and the National Health Commission)

 

Priority 4: Promote the construction of district-level cancer screening and early diagnosis and early treatment centers, summarize, and promote the working mechanism and management model of opportunistic screening for upper gastrointestinal cancer, deepen the construction of healthy cities control) work, and promote the optimization of the national cancer prevention and control platform and its application to residents. (The National Health Commission)

 

Priority 5: Organize and carry out the evaluation of the implementation progress of the grassroots respiratory disease early screening and intervention capacity improvement project and promote the implementation of early screening and comprehensive intervention for high-risk groups of COPD. (The National Health Commission)

 

Priority 6: Taking chronic diseases such as hypertension and diabetes as the starting point, guide all localities to improve the integrated service capabilities of grass-roots chronic disease medical treatment and prevention, and summarize and formulate traditional Chinese medicine rehabilitation programs such as diabetes. (The National Health Commission and the State Administration of Traditional Chinese Medicine)

 

Priority 7: Normalizing the prevention and control of the COVID-19 pneumonia epidemic. Carry out publicity work on the achievement of malaria elimination. Carry out the construction of "snail control and disease prevention forest” and strengthen the quality inspection of the effectiveness of "forest blood control and snail suppression".